Research / Trials currently in follow up


A Randomized, Double-Blind, Parallel-Group, Placebo-and Active-Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder.

  • ‘WET’ Over active bladder for ≥ 3 months
  • Micturition average of ≥ 8 times per 24hr period over 7 days
  • ≥ 3 incontinence episodes over 7 days
  • ≥ 1 urgency episode per 24hr period over 7 days



A Randomized, Double-Blind Comparative study of Abiraterone Acetate + Low Dose Prednisone + ADT Versus ADT Alone, in Newly Diagnosed Pts With High Risk mHNPC.

  • Newly diagnosed (within 3 months prior to randomization) metastatic, hormone naïve prostate cancer.
  • Distant metastatic disease documented by positive bone scan or met lesions on CT/MRI
  • At least 2 of the following:
    • Gleason score of ≥8
    • 3 or more lesions on bone scan
    • Presence of measurable visceral metastasis on CT?MRI (excluding lymph node disease)
    • ECOG grade of 0-2


A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of a Single Intraprostatic Treatment of PRX302 for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

  • Have moderate to severe BPH,
  • Are 50 years of age or older,
  • Do not have evidence of prostate cancer based on a blood test (Prostate-

Specific Antigen - PSA


Evaluate the Safety and Performance of the PAS Device for the Treatment of BPH.

  • Male
  • Age > 50 years
  • Prostate size < 80g
  • IPSS score >/10
  • Qmax ≤ 12ml/s
  • PSA  < 4 or negative biopsy
  • History of inadequate response to medical therapy
  • Patient is mentally capable and willing to sign a study-specific informed consent form
  • Patient is willing and able to comply with all study requirements
  • Schaffer scale ≥ Grade 2

If you are interested in participating in a urological study, please contact Urology Bay of Plenty’s Research Manager, Rachael Hamill, on 07 577 7795 or email